What is the average price target for NATERA INC (NTRA) stock?
28 analysts have analysed NTRA and the average price target is 258.63 USD. This implies a price increase of 30.36% is expected in the next year compared to the current price of 198.4.
NASDAQ:NTRA • US6323071042
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NATERA INC (NTRA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-14 | William Blair | Initiate | Outperform |
| 2026-03-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-02-27 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-27 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-02-27 | Baird | Maintains | Outperform -> Outperform |
| 2026-01-07 | Citigroup | Initiate | Buy |
| 2026-01-05 | Guggenheim | Maintains | Buy -> Buy |
| 2025-12-22 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-15 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-15 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-15 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-08 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-25 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-18 | UBS | Maintains | Buy -> Buy |
| 2025-11-13 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2025-11-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-07 | BTIG | Maintains | Buy -> Buy |
| 2025-11-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-23 | BTIG | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.083B 31.99% | 1.697B 56.75% | 2.306B 35.90% | 2.723B 18.08% | 3.258B 19.65% | 3.876B 18.97% | 4.447B 14.73% | 5.11B 14.91% | 5.83B 14.09% | 6.704B 14.99% | 7.676B 14.50% | |
| EBITDA YoY % growth | -422.148M 19.48% | -191.326M 54.68% | -262.527M -37.21% | -249.492M 4.97% | -7.552M 96.97% | 247.87M 3,381.98% | 308.55M 24.48% | 634.44M 105.62% | N/A | N/A | N/A | |
| EBIT YoY % growth | -446.245M 17.51% | -222.294M 50.19% | -306.011M -37.66% | -293.237M 4.17% | -78.244M 73.32% | 170.74M 318.22% | 257.41M 50.76% | 527.68M 105.00% | 1.228B 132.72% | 1.642B 33.71% | 2.028B 23.51% | |
| Operating Margin | -41.22% | -13.10% | -13.27% | -10.77% | -2.40% | 4.41% | 5.79% | 10.33% | 21.06% | 24.49% | 26.42% | |
| EPS YoY % growth | -3.79 31.96% | -1.53 59.63% | -1.52 0.65% | -1.87 -22.95% | -0.52 72.24% | 1.05 303.09% | 1.81 72.12% | 4.37 140.91% | 10.20 133.46% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.55 -10.70% | -0.54 27.33% | -0.46 28.82% | -0.31 -185.12% | -0.19 65.14% | -0.14 73.29% | -0.02 96.27% | 0.10 131.90% | 0.54 377.53% | 0.56 486.99% | 0.69 4,179.18% | 0.87 792.20% |
| Revenue Q2Q % growth | 630.04M 25.55% | 655.99M 20.01% | 694.14M 17.22% | 743.5M 11.72% | 766.35M 21.64% | 791.05M 20.59% | 832.04M 19.87% | 882.65M 18.72% | 921.13M 20.20% | 958.45M 21.16% | 1.02B 22.59% | 1.102B 24.85% |
| EBITDA Q2Q % growth | -76.649M -9.59% | -74.925M 17.91% | -60.667M 11.03% | -34.674M -240.96% | -1.228M 98.40% | 3.287M 104.39% | 22.392M 136.91% | 36.924M 206.49% | 193.78M 15,876.48% | 184.34M 5,508.15% | 215.8M 863.74% | 261.22M 607.45% |
| EBIT Q2Q % growth | -87.664M -10.72% | -87.021M 21.16% | -74.208M 23.95% | -51.227M -171.26% | -35.437M 59.58% | -28.273M 67.51% | -8.228M 88.91% | 8.649M 116.88% | 174.65M 592.85% | 163.12M 676.96% | 192.77M 2,442.83% | 237.74M 2,648.76% |
All data in USD
28 analysts have analysed NTRA and the average price target is 258.63 USD. This implies a price increase of 30.36% is expected in the next year compared to the current price of 198.4.
NATERA INC (NTRA) will report earnings on 2026-05-07, after the market close.
The consensus EPS estimate for the next earnings of NATERA INC (NTRA) is -0.55 USD and the consensus revenue estimate is 630.04M USD.
The number of analysts covering NATERA INC (NTRA) is 28.